Kala Bio : KALA

KALA

Stock Data

$3.61

$0.77 (26.89%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development and commercialization of therapies using its proprietary nanoparticle-based mucus penetrating particle (MPP) technology for the treatment of eye diseases. The company is headquartered in Watertown, Massachusetts.

All Kala Bio Articles

3 Articles

Ian Cooper | Sep 29, 2025 at 5:08 PM EDT

These Penny Stocks are Dropping Today: IOBT, KALA, BYND

Always be cautious before investing in a penny stock. While some will turn out to be explosive winners, like Advanced…

Lee Jackson | Dec 30, 2022 at 8:34 AM EST

Friday’s Top Analyst Upgrades and Downgrades: AMC, CNH, Opendoor, Tesla and More

Friday's top analyst upgrades and downgrades included AMC Entertainment, CNH Industrial, Kala Pharmaceuticals, Opendoor Technologies, Tesla and TG Therapeutics.

Chris Lange | Mar 9, 2020 at 9:52 AM EDT

How Kala Pharma Is Surviving Monday’s Market Carnage

Kala Pharmaceuticals said that it had positive topline results from its late-stage clinical trial for the treatment of dry eye…

Kala Bio : KALA

KALA

$3.61

All Kala Bio Articles

These Penny Stocks are Dropping Today: IOBT, KALA, BYND

Friday’s Top Analyst Upgrades and Downgrades: AMC, CNH, Opendoor, Tesla and More

How Kala Pharma Is Surviving Monday’s Market Carnage

‘You’re Gonna Go Into Retirement Broke and Wait on Mom to Die’: Dave Ramsey’s Reality Check for a Caller Eyeing His Inheritance

“You Don’t Want to Pass the Burden of Investments Down to Your Daughter”: Suze Orman’s Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

EEM’s 0.69% Fee Quietly Costs You $690 a Year, but Your Cheaper Alternative Charges $90

'You're Gonna Go Into Retirement Broke and Wait on Mom to Die': Dave Ramsey's Reality Check for a Caller Eyeing His Inheritance

"You Don't Want to Pass the Burden of Investments Down to Your Daughter": Suze Orman's Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

‘You’re Gonna Go Into Retirement Broke and Wait on Mom to Die’: Dave Ramsey’s Reality Check for a Caller Eyeing His Inheritance

“You Don’t Want to Pass the Burden of Investments Down to Your Daughter”: Suze Orman’s Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

Kala Bio : KALA

KALA

$3.61

All Kala Bio Articles

These Penny Stocks are Dropping Today: IOBT, KALA, BYND

Friday’s Top Analyst Upgrades and Downgrades: AMC, CNH, Opendoor, Tesla and More

How Kala Pharma Is Surviving Monday’s Market Carnage

‘You’re Gonna Go Into Retirement Broke and Wait on Mom to Die’: Dave Ramsey’s Reality Check for a Caller Eyeing His Inheritance

“You Don’t Want to Pass the Burden of Investments Down to Your Daughter”: Suze Orman’s Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

EEM’s 0.69% Fee Quietly Costs You $690 a Year, but Your Cheaper Alternative Charges $90

Featured Reads

'You're Gonna Go Into Retirement Broke and Wait on Mom to Die': Dave Ramsey's Reality Check for a Caller Eyeing His Inheritance

"You Don't Want to Pass the Burden of Investments Down to Your Daughter": Suze Orman's Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings